UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 90 - 98
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - surgery | Follow-Up Studies | Humans | Middle Aged | Fatigue - chemically induced | Receptors, Estrogen - analysis | Receptors, Progesterone - analysis | Taxoids - therapeutic use | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Liver Neoplasms - secondary | Neutropenia - chemically induced | Taxoids - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Tegafur - adverse effects | Tegafur - therapeutic use | Paclitaxel - adverse effects | Survival Rate | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Disease Progression | Oxonic Acid - adverse effects | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Breast Neoplasms - pathology | Antimetabolites, Antineoplastic - adverse effects | Aged | Edema - chemically induced | Receptor, ErbB-2 - analysis | Health Status | Drug Combinations | Antimitotic agents | Medical colleges | Chemotherapy | Product development | Breast cancer | Metastasis | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 8/2019, Volume 176, Issue 3, pp. 631 - 635
Medicine & Public Health | Prospective cohort study | Trial effect | Oncology | SELECT BC | Overall survival | Randomized control trial | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Patient Participation | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Biomarkers, Tumor | Neoplasm Metastasis | Adult | Female | Outcome Assessment, Health Care | Kaplan-Meier Estimate | Survival Rate | Treatment Outcome | Combined Modality Therapy | Oxonic Acid - administration & dosage | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Breast Neoplasms - mortality | Aged | Breast Neoplasms - diagnosis | Neoplasm Staging | Bridged-Ring Compounds - administration & dosage | Drug Combinations | Medical research | Care and treatment | Chemotherapy | Prognosis | Patient outcomes | Clinical trials | Medicine, Experimental | Metastasis | Research | Comparative analysis | Cancer | Index Medicus
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 5/2012, Volume 133, Issue 1, pp. 227 - 236
Medicine & Public Health | Anastrozole | Adverse event | Oncology | Breast cancer | Exemestane | Tamoxifen | Quality of life | Life Sciences & Biomedicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Chemotherapy | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Breast Neoplasms - surgery | Triazoles - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Tamoxifen - administration & dosage | Nitriles - administration & dosage | Depression - chemically induced | Postmenopause | Female | Surveys and Questionnaires | Maintenance Chemotherapy | Chemotherapy, Adjuvant | Carcinoma - drug therapy | Neoplasms, Hormone-Dependent - surgery | Stress, Psychological - chemically induced | Carcinoma - surgery | Treatment Outcome | Breast Neoplasms - drug therapy | Carcinoma - psychology | Androstadienes - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - psychology | Neoplasms, Hormone-Dependent - psychology | Quality of Life | Aged | Neoplasms, Hormone-Dependent - drug therapy | Care and treatment | Oncology, Experimental | Adjuvant treatment | Postmenopausal women | Research | Stress (Psychology) | Cancer | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9762, pp. 321 - 331
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | General aspects | Medical sciences | Tumors | Receptors, Estrogen - metabolism | Adenocarcinoma - pathology | Humans | Middle Aged | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Disease-Free Survival | Adenocarcinoma - metabolism | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Aged, 80 and over | Postmenopause | Adult | Breast Neoplasms - mortality | Female | Aged | Androstadienes - therapeutic use | Early Diagnosis | Adenocarcinoma - mortality | Disease | Womens health | Meetings | Data collection | Breast cancer | Mammography | Family medical history | Clinical medicine | Cancer therapies | Index Medicus | Abridged Index Medicus | Ethics | Side effects | Hospitals | thromboembolism | survival | musculoskeletal system | post-menopause | Cancer
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 1/2010, Volume 119, Issue 1, pp. 127 - 136
Medicine & Public Health | First-line therapy | Docetaxel | Oncology | Metastatic breast cancer | Combination therapy | Trastuzumab | Life Sciences & Biomedicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Receptor, ErbB-2 - biosynthesis | Drug Administration Schedule | Humans | Middle Aged | Proportional Hazards Models | Breast Neoplasms - drug therapy | Disease Progression | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Disease-Free Survival | Taxoids - administration & dosage | Neoplasm Metastasis | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Antimitotic agents | Care and treatment | Clinical trials | Breast cancer | Product development | Metastasis | Toy industry | Antineoplastic agents | Index Medicus
Journal Article
BMC cancer, ISSN 1471-2407, 11/2017, Volume 17, Issue 1, pp. 773 - 773
Journal Article
7.
Full Text
Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics
Nature communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1177 - 15
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Recombinant Proteins - metabolism | Cysteine - analogs & derivatives | Oxidation-Reduction | Humans | Hydrogen Sulfide - chemistry | Sulfides - chemistry | Mitochondria - metabolism | Cysteine - chemistry | Mice, Knockout | Tandem Mass Spectrometry | Animals | Energy Metabolism | Disulfides - chemistry | Computer Simulation | Escherichia coli - metabolism | Sulfhydryl Compounds - chemistry | Mice | Protein Processing, Post-Translational | Amino Acyl-tRNA Synthetases - metabolism | Sulfide | Enzymes | Oxidative stress | Cysteine | Translation | Biosynthesis | tRNA Cys | Mammals | Mammalian cells | Hydrogen sulfide | Proteins | Signaling | Mitochondria | Bioenergetics | E coli | Post-translation | Physiology | Disruption | Aberration | Chemical synthesis | Cysteine-tRNA ligase | Index Medicus
Journal Article
Current nutrition and food science, ISSN 1573-4013, 2013, Volume 9, Issue 3, pp. 194 - 200
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 11/2014, Volume 148, Issue 2, pp. 337 - 343
Medicine & Public Health | Anastrozole | Oncology | Breast cancer | Tamoxifen | Adjuvant therapy | Hormonal therapy | Life Sciences & Biomedicine | Science & Technology | Receptors, Estrogen - metabolism | Prognosis | Follow-Up Studies | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Neoplasm Recurrence, Local - drug therapy | Neoplasm Recurrence, Local - mortality | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | Neoplasm Recurrence, Local - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Triazoles - therapeutic use | Survival Rate | Breast Neoplasms - drug therapy | Breast Neoplasms - pathology | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Aged | Neoplasm Staging | Nitriles - therapeutic use | Care and treatment | Adjuvant treatment | Postmenopausal women | Hormones | Comparative analysis | Health aspects | Cancer | Index Medicus
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 5/2011, Volume 127, Issue 1, pp. 143 - 152
Aromatase inhibitor | Medicine & Public Health | Oncology | Breast cancer | Adjuvant endocrine therapy | Tamoxifen | Quality of life | Life Sciences & Biomedicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Tumors | Breast Neoplasms - surgery | Humans | Middle Aged | Treatment Outcome | Breast Neoplasms - drug therapy | Breast Neoplasms - psychology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Quality of Life | Female | Aged | Nitriles - therapeutic use | Triazoles - therapeutic use | Care and treatment | Cancer patients | Adjuvant treatment | Postmenopausal women | Product development | Stress (Psychology) | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 2527 - 2527
Journal Article
Japanese journal of clinical oncology, ISSN 0368-2811, 08/2020, Volume 50, Issue 8, pp. 873 - 881
Journal Article